Cáncer de pulmón microcítico: revisión

Twenty percent of all lung cancers are of small cells (CPCP). More than half occur to people aged 60 and more. Due to its fast dissemination, most of them show symptoms when diagnosed (90%). These symptoms can be derived from its locoregional extension, metastases or can have a paraneoplastical orig...

Full description

Bibliographic Details
Main Authors: Carmen Guillén, María José Molina
Format: Article
Language:Spanish
Published: Universidad Complutense de Madrid 2006-01-01
Series:Psicooncologia
Subjects:
Online Access:http://revistas.ucm.es/index.php/PSIC/article/view/16666
_version_ 1811215802970406912
author Carmen Guillén
María José Molina
author_facet Carmen Guillén
María José Molina
author_sort Carmen Guillén
collection DOAJ
description Twenty percent of all lung cancers are of small cells (CPCP). More than half occur to people aged 60 and more. Due to its fast dissemination, most of them show symptoms when diagnosed (90%). These symptoms can be derived from its locoregional extension, metastases or can have a paraneoplastical origin. Anamnesis and thorough physical exploration are essential for the initial evaluation and adequate treatment. In addition to a blood analysis with determination of enzymes such as lactate dehydrogenase which helps in prognosis, thorax and abdominal computed tomography (CT), bone gammagraphy and cerebral CT or magnetic resonance imaging (MRI) allow optimum estadification. Although CPCP is chemo- and radio-sensitive, small progress has been achieved in the last years and its mortality rate is high. The objective of this paper is to revise all these aspects related to CPCP.
first_indexed 2024-04-12T06:28:31Z
format Article
id doaj.art-bf04a5df64204abd8e908b7d41bae218
institution Directory Open Access Journal
issn 1696-7240
1988-8287
language Spanish
last_indexed 2024-04-12T06:28:31Z
publishDate 2006-01-01
publisher Universidad Complutense de Madrid
record_format Article
series Psicooncologia
spelling doaj.art-bf04a5df64204abd8e908b7d41bae2182022-12-22T03:44:05ZspaUniversidad Complutense de MadridPsicooncologia1696-72401988-82872006-01-013224926716681Cáncer de pulmón microcítico: revisiónCarmen GuillénMaría José MolinaTwenty percent of all lung cancers are of small cells (CPCP). More than half occur to people aged 60 and more. Due to its fast dissemination, most of them show symptoms when diagnosed (90%). These symptoms can be derived from its locoregional extension, metastases or can have a paraneoplastical origin. Anamnesis and thorough physical exploration are essential for the initial evaluation and adequate treatment. In addition to a blood analysis with determination of enzymes such as lactate dehydrogenase which helps in prognosis, thorax and abdominal computed tomography (CT), bone gammagraphy and cerebral CT or magnetic resonance imaging (MRI) allow optimum estadification. Although CPCP is chemo- and radio-sensitive, small progress has been achieved in the last years and its mortality rate is high. The objective of this paper is to revise all these aspects related to CPCP.http://revistas.ucm.es/index.php/PSIC/article/view/16666CancerLungSmall-cellChemotherapy
spellingShingle Carmen Guillén
María José Molina
Cáncer de pulmón microcítico: revisión
Psicooncologia
Cancer
Lung
Small-cell
Chemotherapy
title Cáncer de pulmón microcítico: revisión
title_full Cáncer de pulmón microcítico: revisión
title_fullStr Cáncer de pulmón microcítico: revisión
title_full_unstemmed Cáncer de pulmón microcítico: revisión
title_short Cáncer de pulmón microcítico: revisión
title_sort cancer de pulmon microcitico revision
topic Cancer
Lung
Small-cell
Chemotherapy
url http://revistas.ucm.es/index.php/PSIC/article/view/16666
work_keys_str_mv AT carmenguillen cancerdepulmonmicrociticorevision
AT mariajosemolina cancerdepulmonmicrociticorevision